PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lanthio Pharma, a MorphoSys AG company, Rozenburglaan 13B, 9727 DL, Groningen, the Netherlands.\', \'Lanthio Pharma, a MorphoSys AG company, Rozenburglaan 13B, 9727 DL, Groningen, the Netherlands. moll@lanthiopharma.com.\', \'Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, the Netherlands. moll@lanthiopharma.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s10020-020-00211-0
?:doi
?:hasPublicationType
?:journal
  • Molecular medicine (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 32807075
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32807075>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32807075>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all